Luciana Pizzatti Barboza
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências Matemáticas e da Natureza
Unidade:
Instituto de Química
Departamento:
Departamento de Bioquímica/IQ
Formação:
-
Instituto Nacional de Câncer
| Pós-Doutorado | 2005 - 2006
-
Universidade Federal do Rio de Janeiro
| Pós-Doutorado | 2004 - 2005
-
Universidade Federal do Rio de Janeiro
Ciências Biológicas (Biofísica) | Doutorado | 2000 - 2004
-
Universidade Federal do Rio de Janeiro
Ciências Biológicas | Graduação | 1997 - 1999
Laboratórios:
Nuvens de Palavras:
Artigos:
(88.89% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals | 10.1038/s41397-021-00254-4 | 2022 |
| Extracellular Vesicles From Stored Red Blood Cells Convey Heme and Induce Spic Expression on Human Monocytes | 10.3389/fimmu.2022.833286 | 2022 |
| In-depth proteomic analysis reveals unique subtype-specific signatures in human small cell lung cancer | 10.1002/ctm2.1060 | 2022 |
| Investigation of a new oxazolidine derivative in human resistance acute leukemia cells: deciphering its mechanism of action by label-free proteomic | 10.1007/s00210-020-02024-8 | 2021 |
| The human melanoma proteome atlas-Defining the molecular pathology | 10.1002/ctm2.473 | 2021 |
| The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome | 10.1002/ctm2.451 | 2021 |
| Mapping the Melanoma Plasma Proteome (MPP) Using Single-Shot Proteomics Interfaced with the WiMT Database | 10.3390/cancers13246224 | 2021 |
| Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives | 10.1021/acs.jproteome.0c00850 | 2020 |
| Toxicoproteomics Disclose Pesticides as Downregulators of TNF-α, IL-1β and Estrogen Receptor Pathways in Breast Cancer Women Chronically Exposed | 10.3389/fonc.2020.01698 | 2020 |
| Gene doping and genomic science in sports: where are we? | 10.4155/bio-2020-0093 | 2020 |
| Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer | 10.1155/2019/5357649 | 2019 |
| Identifying potential markers in Breast Cancer subtypes using plasma label-free proteomics | 10.1016/j.jprot.2016.07.030 | 2017 |
| Doping control analysis at the Rio 2016 Olympic and Paralympic Games | 10.1002/dta.2329 | 2017 |
| Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer | 10.1007/s00280-017-3384-8 | 2017 |
| Early downregulation of acute phase proteins after doxorubicin exposition in patients with breast cancer | 10.1007/s13277-015-4203-7 | 2016 |
| Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016 | 10.4155/bio-2016-0147 | 2016 |
| Clinical proteomics in cancer: Where we are | 10.1016/j.canlet.2016.08.014 | 2016 |
| Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1 β /cNOS/NO Pathway | 10.1155/2015/392918 | 2015 |
| The positive is inside the negative: HER2-negative tumors can express the HER2 intracellular domain and present a HER2-positive phenotype | 10.1016/j.canlet.2014.11.029 | 2015 |
| Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle | 10.2174/0929867321666140601164647 | 2014 |
| Discovering the infectome of human endothelial cells challenged with Aspergillus fumigatus applying a mass spectrometry label-free approach | 10.1016/j.jprot.2013.07.003 | 2014 |
| Label-Free Proteomic Analysis of Breast Cancer Molecular Subtypes | 10.1021/pr500676x | 2014 |
| Mechanisms of kidney repair by human mesenchymal stromal cells after ischemia: A comprehensive view using label-free MS E | 10.1002/pmic.201300084 | 2014 |
| Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics | 10.1016/j.canlet.2012.11.020 | 2013 |
| Stability of human mesenchymal stem cells during culture: considerations for cell therapy | 10.1111/cpr.12002 | 2013 |
| How can Proteomics Reach Cancer Biomarkers? | 10.2174/1570164611310020006 | 2013 |
| Wnt/ß-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia | 10.1186/1471-2407-12-303 | 2012 |
| Neuroproteomics: an insight into ALS | 10.1179/1743132812y.0000000092 | 2012 |
| Label-free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance | 10.1002/pmic.201200066 | 2012 |
| A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line | 10.1186/1477-5956-10-23 | 2012 |
| Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of Chronic Myeloid Leukemia | 10.1186/1475-2867-12-28 | 2012 |
| SUZ12 is a candidate target of the non-canonical WNT pathway in the progression of chronic myeloid leukemia. | 10.1002/gcc.20722 | 2010 |
| Similar proteomic profiles of human mesenchymal stromal cells from different donors | 10.1080/14653240902783268 | 2009 |
| RUNX1T1 is overexpressed in imatinib mesylate-resistant cells. | 10.3892/mmr_00000153 | 2009 |
| SPARC-like1 mRNA is overexpressed in human uterine leiomyoma | 10.3892/mmr.1.4.571 | 2008 |
| Corrigendum to -Changes in protein expression due to deleterious mutations in the FA/BRCA pathway- [Biochem. Biophys. Res. Commun. 364 (2007) 755-760] | 10.1016/j.bbrc.2008.05.112 | 2008 |
| Otx2 is a putative candidate to activate mice Msx1 gene from distal enhancer | 10.1016/j.bbrc.2007.04.190 | 2007 |
| SMAD8 binding to mice MSX1 basal promoter is required for transcriptional | 10.1042/BJ20050327 | 2006 |
| Altered protein profile in chronic myeloid leukemia chronic phase identified by a comparative proteomic study | 10.1016/j.bbapap.2006.02.004 | 2006 |
| Proteoma do Câncer | 2005 | |
| Tthe Chronic Myeloid Leukemia protein profile: a proteomic study | 2003 | |
| Differentially expressed genes in Chornic Myeloid Leukemia: a new blastic crisis marker | 2003 | |
| Analysis of Transcripts of the Translocation t(9;22) in Chronic Myeloid Leukemia | 2001 | |
| Proteomics in Chronic Myeloid Leukemia | 2001 | |
| Análise dos transcritos da translocação t(9;22) em Leucemia Mielóide Crônica | 10.1590/S1516-84842000000200005 | 2000 |
Eventos:
(0.00% eventos com DOI)